Research notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

2Q26 result: in-line, capital returns remain a standout

Newmont Corporation
3:27pm
July 28, 2026
A broadly in-line result with small beats and misses across the board despite the Cadia disruption, with the qoq earnings decline driven by a lower realised gold price rather than operating performance. NEM’s capital returns remain best in class among its gold peers, with US$1.9bn returned this quarter implying a capital return yield of around 7-8%. Maintain BUY with a A$194ps target price.

International Spotlight

RTX Corp
3:27pm
July 28, 2026
RTX Corporation is an aerospace and defence company that provides systems and services for commercial, military, and government customers worldwide.

International Spotlight

Nestlé
3:27pm
July 28, 2026
Nestlé SA is the world’s largest food and beverage company. It engages in the manufacture, supply and production of prepared dishes and cooking aids, milk-based products, pharmaceuticals and ophthalmic goods, baby foods and cereals.

International Spotlight

Honeywell International Inc.
3:27pm
July 28, 2026
Honeywell International is a world-wide diversified technology and manufacturing company. It consists of four key segments: (1) Aerospace, (2) Performance Materials & Technologies, (3) Building Technologies, and (4) Safety & Productivity Solutions. The company was founded in 1885 and is headquartered in Charlotte, North Carolina, United States.

International Spotlight

General Motors Company
3:27pm
July 28, 2026
General Motors Company (GM-US), headquartered in Detroit, is a global automotive company known for brands like Chevrolet and Cadillac, offering a diverse portfolio of vehicles. A market leader with considerable scale, GM has global operations and employs over 165,000 staff worldwide.

International Spotlight

Netflix
3:27pm
July 28, 2026
Netflix, Inc. provides entertainment services. It offers TV series, documentaries, feature films, and games across various genres and languages. The company also provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, TV set-top boxes, and mobile devices. It has operations in approximately 190 countries and streams in over 30 languages. The company was incorporated in 1997 and is headquartered in Los Gatos, California.

Executing well

6K Additive
3:27pm
July 28, 2026
6KA delivered a strong June quarter update, with revenue up 63% to US$7.1m. This implies an annualised run-rate of ~US$28m, up from ~US$25m in 1Q26. Both the Powder (+63%) and Alloy (+62%) segments delivered strong revenue growth on the pcp, with a higher order backlog (+23% qoq) supporting ongoing sales momentum in 2H26. Pleasingly, 6KA said the Burgettstown expansion remains on schedule, with initial production from the expanded facility expected by the end of CY26. On the back of the strong 2Q26 performance, we increase CY26F revenue by 5% to US$24.0m. While our CY27 and CY28 forecasts remain unchanged as 6KA enters the critical stages of the Burgettstown expansion over coming months, strong execution could see upside risk to our medium-term assumptions. Our target price rises marginally to $1.31 (from $1.30) and we maintain our SPECULATIVE BUY rating. In our view, 6KA remains well positioned to benefit from strong demand in metal additive manufacturing and US initiatives to reshore critical minerals, supported by its fully domestic powder production which reduces reliance on foreign-controlled feedstock.

International Spotlight

Genuine Parts Company
3:27pm
July 28, 2026

Rough night for revenue, sound sleep for EBITDA

SomnoMed
3:27pm
July 28, 2026
SOM missed FY26 revenue guidance on European reimbursement changes, though disciplined cost control kept EBITDA on target, a demand problem rather than a margin problem. The margin upgrade case we've backed since February isn't dead, but it’s gotten harder with the historical European engine throttling back. Investors may need to see some reversal signs here before getting more positive. Our target price is reduced to A$0.75 (from A$0.99) and retain a Speculative Buy.

Some progress but needs to accelerate SOZO growth

ImpediMed
3:27pm
July 28, 2026
IPD posted its 4Q26 report which showed some progress; however, the installed base growth is still below that needed to achieve break-even. The A$5m cost saving initiatives are expected to deliver results evenly over the year, which should see operating cash outflow reduce significantly. We have moderated our revenue forecasts, which have been offset by a lower cost base. As a result, our target price has reduced to A$0.01 (was A$0.02). We maintain a SPECULATIVE BUY recommendation noting this is a high risk play as the company moves towards break-even.

News & insights

Raymond Chan, Head of the Asian Desk at Morgans, joins SBS World News to unpack rising oil prices, US rate expectations, the return of the US dollar, and what to watch this ASX reporting season.
Read more
Get across the key themes shaping ASX reporting season in August 2026, from earnings trends to dividend and tax changes affecting investors.
Read more
See how global share markets performed in June 2026, from US tech gains to Asian and Australian market strength. Read Scott Fraser's update
Read more